ABT logo

Abbott Laboratories (ABT) Gross profit

Annual gross profit:

$23.24B+$1.11B(+5.01%)
December 31, 2024

Summary

  • As of today (April 16, 2025), ABT annual gross profit is $23.24 billion, with the most recent change of +$1.11 billion (+5.01%) on December 31, 2024.
  • During the last 3 years, ABT annual gross profit has fallen by -$1.29 billion (-5.27%).
  • ABT annual gross profit is now -5.27% below its all-time high of $24.54 billion, reached on December 31, 2021.

Performance

ABT Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

quarterly gross profit:

$6.03B+$95.00M(+1.60%)
December 31, 2024

Summary

  • As of today (April 16, 2025), ABT quarterly gross profit is $6.03 billion, with the most recent change of +$95.00 million (+1.60%) on December 31, 2024.
  • Over the past year, ABT quarterly gross profit has increased by +$347.00 million (+6.10%).
  • ABT quarterly gross profit is now -12.68% below its all-time high of $6.91 billion, reached on March 31, 2022.

Performance

ABT quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

TTM gross profit:

$23.24B+$347.00M(+1.52%)
December 31, 2024

Summary

  • As of today (April 16, 2025), ABT TTM gross profit is $23.24 billion, with the most recent change of +$347.00 million (+1.52%) on December 31, 2024.
  • Over the past year, ABT TTM gross profit has increased by +$1.11 billion (+5.01%).
  • ABT TTM gross profit is now -12.08% below its all-time high of $26.44 billion, reached on June 30, 2022.

Performance

ABT TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

ABT Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.0%+6.1%+5.0%
3 y3 years-5.3%+6.1%+5.0%
5 y5 years+24.5%+6.1%+5.0%

ABT Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-5.3%+5.0%-12.7%+11.4%-12.1%+5.9%
5 y5-year-5.3%+24.5%-12.7%+48.4%-12.1%+28.4%
alltimeall time-5.3%+1294.0%-12.7%+212.1%-12.1%+2660.2%

Abbott Laboratories Gross profit History

DateAnnualQuarterlyTTM
Dec 2024
$23.24B(+5.0%)
$6.03B(+1.6%)
$23.24B(+1.5%)
Sep 2024
-
$5.94B(+2.8%)
$22.90B(+1.8%)
Jun 2024
-
$5.77B(+5.0%)
$22.50B(+1.3%)
Mar 2024
-
$5.50B(-3.2%)
$22.22B(+0.4%)
Dec 2023
$22.13B(-9.7%)
$5.68B(+2.7%)
$22.13B(+0.9%)
Sep 2023
-
$5.54B(+0.8%)
$21.95B(-1.1%)
Jun 2023
-
$5.50B(+1.5%)
$22.19B(-3.6%)
Mar 2023
-
$5.42B(-1.5%)
$23.02B(-6.1%)
Dec 2022
$24.51B(-0.1%)
$5.50B(-4.9%)
$24.51B(-4.7%)
Sep 2022
-
$5.78B(-8.6%)
$25.71B(-2.7%)
Jun 2022
-
$6.32B(-8.5%)
$26.44B(+4.1%)
Mar 2022
-
$6.91B(+3.1%)
$25.39B(+3.5%)
Dec 2021
$24.54B(+25.2%)
$6.70B(+3.0%)
$24.54B(+2.1%)
Sep 2021
-
$6.50B(+23.3%)
$24.04B(+7.2%)
Jun 2021
-
$5.28B(-12.9%)
$22.43B(+5.7%)
Mar 2021
-
$6.05B(-2.5%)
$21.21B(+8.2%)
Dec 2020
$19.61B(+5.0%)
$6.21B(+27.0%)
$19.61B(+7.3%)
Sep 2020
-
$4.89B(+20.2%)
$18.28B(+0.9%)
Jun 2020
-
$4.07B(-8.5%)
$18.11B(-3.4%)
Mar 2020
-
$4.45B(-8.9%)
$18.74B(+0.4%)
Dec 2019
$18.67B(+4.5%)
$4.88B(+3.4%)
$18.67B(+1.7%)
Sep 2019
-
$4.72B(+0.4%)
$18.37B(+1.3%)
Jun 2019
-
$4.70B(+7.4%)
$18.14B(+1.2%)
Mar 2019
-
$4.38B(-4.4%)
$17.92B(+0.3%)
Dec 2018
$17.87B(+19.3%)
$4.57B(+1.9%)
$17.87B(+1.5%)
Sep 2018
-
$4.49B(+0.1%)
$17.61B(+3.1%)
Jun 2018
-
$4.49B(+3.7%)
$17.07B(+6.5%)
Mar 2018
-
$4.32B(+0.4%)
$16.03B(+7.0%)
Dec 2017
$14.98B(+27.4%)
$4.31B(+9.0%)
$14.98B(+10.0%)
Sep 2017
-
$3.95B(+14.6%)
$13.63B(+7.4%)
Jun 2017
-
$3.45B(+5.3%)
$12.69B(+3.3%)
Mar 2017
-
$3.27B(+10.9%)
$12.29B(+4.5%)
Dec 2016
$11.76B(+0.9%)
$2.95B(-2.2%)
$11.76B(-0.3%)
Sep 2016
-
$3.02B(-1.0%)
$11.79B(+0.9%)
Jun 2016
-
$3.05B(+11.0%)
$11.68B(+0.8%)
Mar 2016
-
$2.75B(-7.9%)
$11.59B(-0.6%)
Dec 2015
$11.66B(+5.7%)
$2.98B(+2.5%)
$11.66B(-0.3%)
Sep 2015
-
$2.91B(-1.5%)
$11.70B(+1.3%)
Jun 2015
-
$2.95B(+4.8%)
$11.55B(+1.6%)
Mar 2015
-
$2.82B(-6.7%)
$11.36B(+3.0%)
Dec 2014
$11.03B(+5.4%)
$3.02B(+9.4%)
$11.03B(+3.2%)
Sep 2014
-
$2.76B(-0.3%)
$10.69B(+1.8%)
Jun 2014
-
$2.77B(+11.6%)
$10.49B(-1.2%)
Mar 2014
-
$2.48B(-7.3%)
$10.63B(-4.2%)
Dec 2013
$10.46B(+3.1%)
$2.67B(+4.1%)
$11.09B(+11.8%)
Sep 2013
-
$2.57B(-11.4%)
$9.92B(-2.0%)
Jun 2013
-
$2.90B(-1.5%)
$10.13B(-0.4%)
Mar 2013
-
$2.95B(+95.4%)
$10.17B(+0.2%)
Dec 2012
$10.15B(-10.9%)
$1.51B(-45.7%)
$10.15B(+211.1%)
Sep 2012
-
$2.78B(-5.7%)
$3.26B(-48.5%)
Jun 2012
-
$2.94B(+0.6%)
$6.33B(-30.7%)
Mar 2012
-
$2.92B(-154.3%)
$9.13B(-19.8%)
Dec 2011
$11.39B(-44.4%)
-$5.38B(-192.1%)
$11.39B(-49.8%)
Sep 2011
-
$5.84B(+1.7%)
$22.69B(+4.2%)
Jun 2011
-
$5.75B(+10.9%)
$21.78B(+2.2%)
Mar 2011
-
$5.18B(-12.5%)
$21.32B(+4.0%)
Dec 2010
$20.50B(+16.8%)
$5.92B(+20.1%)
$20.50B(+4.7%)
Sep 2010
-
$4.93B(-6.6%)
$19.58B(+2.8%)
Jun 2010
-
$5.28B(+21.1%)
$19.05B(+5.1%)
Mar 2010
-
$4.36B(-12.8%)
$18.14B(+3.3%)
Dec 2009
$17.56B(+3.8%)
$5.01B(+13.7%)
$17.56B(+1.4%)
Sep 2009
-
$4.40B(+0.8%)
$17.32B(+1.5%)
Jun 2009
-
$4.37B(+15.4%)
$17.07B(+1.0%)
Mar 2009
-
$3.78B(-20.7%)
$16.89B(-0.1%)
Dec 2008
$16.92B(+16.7%)
$4.77B(+15.1%)
$16.92B(+4.4%)
Sep 2008
-
$4.14B(-1.2%)
$16.20B(+4.1%)
Jun 2008
-
$4.19B(+10.2%)
$15.57B(+4.2%)
Mar 2008
-
$3.80B(-6.3%)
$14.94B(+3.1%)
Dec 2007
$14.49B(+14.5%)
$4.06B(+15.6%)
$14.49B(+5.1%)
Sep 2007
-
$3.51B(-1.5%)
$13.78B(+2.5%)
Jun 2007
-
$3.57B(+6.3%)
$13.45B(+3.5%)
Mar 2007
-
$3.35B(+0.0%)
$13.00B(+4.3%)
Dec 2006
$12.66B
$3.35B(+5.3%)
$12.47B(+0.9%)
DateAnnualQuarterlyTTM
Sep 2006
-
$3.18B(+2.3%)
$12.35B(+4.0%)
Jun 2006
-
$3.11B(+10.3%)
$11.88B(+1.9%)
Mar 2006
-
$2.82B(-12.9%)
$11.66B(-0.3%)
Dec 2005
$11.70B(+8.3%)
$3.24B(+19.6%)
$11.70B(+1.8%)
Sep 2005
-
$2.71B(-6.4%)
$11.49B(+1.2%)
Jun 2005
-
$2.89B(+1.1%)
$11.35B(+2.3%)
Mar 2005
-
$2.86B(-5.5%)
$11.09B(+2.7%)
Dec 2004
$10.80B(+13.6%)
$3.03B(+17.9%)
$10.80B(+3.1%)
Sep 2004
-
$2.57B(-2.6%)
$10.47B(+2.4%)
Jun 2004
-
$2.63B(+2.6%)
$10.22B(+3.6%)
Mar 2004
-
$2.57B(-4.9%)
$9.86B(+1.9%)
Dec 2003
$9.51B(+12.4%)
$2.70B(+16.4%)
$9.68B(+11.0%)
Sep 2003
-
$2.32B(+1.8%)
$8.72B(+0.5%)
Jun 2003
-
$2.28B(-4.4%)
$8.68B(+1.5%)
Mar 2003
-
$2.38B(+36.6%)
$8.55B(+1.1%)
Dec 2002
$8.46B(-0.9%)
$1.74B(-23.3%)
$8.46B(-6.8%)
Sep 2002
-
$2.27B(+5.8%)
$9.08B(+1.5%)
Jun 2002
-
$2.15B(-6.3%)
$8.95B(+0.4%)
Mar 2002
-
$2.29B(-3.0%)
$8.91B(+4.4%)
Dec 2001
$8.54B(+13.7%)
$2.36B(+10.5%)
$8.54B(+4.3%)
Sep 2001
-
$2.14B(+1.1%)
$8.18B(+4.3%)
Jun 2001
-
$2.12B(+10.4%)
$7.84B(+3.6%)
Mar 2001
-
$1.92B(-4.6%)
$7.57B(+0.8%)
Dec 2000
$7.51B(-6.5%)
$2.01B(+11.4%)
$7.51B(-9.3%)
Sep 2000
-
$1.80B(-2.0%)
$8.28B(+3.2%)
Jun 2000
-
$1.84B(-0.9%)
$8.02B(-0.1%)
Mar 2000
-
$1.86B(-33.1%)
$8.02B(-0.0%)
Dec 1999
$8.03B(+1.7%)
$2.78B(+79.5%)
$8.03B(+9.1%)
Sep 1999
-
$1.55B(-16.1%)
$7.36B(-4.1%)
Jun 1999
-
$1.84B(-0.9%)
$7.67B(+1.0%)
Mar 1999
-
$1.86B(-11.7%)
$7.59B(-1.2%)
Dec 1998
$7.89B(+4.3%)
$2.11B(+13.4%)
$7.69B(+0.9%)
Sep 1998
-
$1.86B(+5.1%)
$7.62B(+0.5%)
Jun 1998
-
$1.77B(-9.5%)
$7.59B(+1.1%)
Mar 1998
-
$1.96B(-4.1%)
$7.50B(+3.9%)
Dec 1997
$7.57B(+8.6%)
$2.04B(+12.0%)
$7.22B(-5.1%)
Sep 1997
-
$1.82B(+8.2%)
$7.61B(+4.9%)
Jun 1997
-
$1.68B(+0.7%)
$7.25B(-0.4%)
Mar 1997
-
$1.67B(-31.1%)
$7.28B(-0.1%)
Dec 1996
$6.97B(+22.5%)
$2.43B(+65.2%)
$7.29B(+14.3%)
Sep 1996
-
$1.47B(-14.2%)
$6.38B(+2.4%)
Jun 1996
-
$1.71B(+1.9%)
$6.23B(+5.0%)
Mar 1996
-
$1.68B(+10.8%)
$5.93B(+4.3%)
Dec 1995
$5.69B(+10.2%)
$1.52B(+14.8%)
$5.69B(+1.8%)
Sep 1995
-
$1.32B(-6.6%)
$5.59B(+1.5%)
Jun 1995
-
$1.41B(-1.5%)
$5.50B(+2.9%)
Mar 1995
-
$1.44B(+1.4%)
$5.35B(+3.6%)
Dec 1994
$5.16B(+9.3%)
$1.42B(+14.2%)
$5.16B(+11.0%)
Sep 1994
-
$1.24B(-1.4%)
$4.65B(-0.6%)
Jun 1994
-
$1.26B(+0.5%)
$4.68B(-1.3%)
Mar 1994
-
$1.25B(+38.3%)
$4.74B(+0.4%)
Dec 1993
$4.72B(-1.1%)
$904.32M(-28.7%)
$4.72B(-7.5%)
Sep 1993
-
$1.27B(-3.9%)
$5.11B(+1.6%)
Jun 1993
-
$1.32B(+7.1%)
$5.03B(+3.4%)
Mar 1993
-
$1.23B(-4.4%)
$4.86B(+1.8%)
Dec 1992
$4.77B(+16.0%)
$1.29B(+8.5%)
$4.77B(+3.1%)
Sep 1992
-
$1.19B(+3.0%)
$4.63B(+4.7%)
Jun 1992
-
$1.15B(+0.6%)
$4.42B(+3.5%)
Mar 1992
-
$1.15B(+0.2%)
$4.28B(+3.9%)
Dec 1991
$4.12B(+14.2%)
$1.14B(+16.7%)
$4.12B(+3.7%)
Sep 1991
-
$980.90M(-2.3%)
$3.97B(+2.9%)
Jun 1991
-
$1.00B(+1.7%)
$3.86B(+2.9%)
Mar 1991
-
$986.70M(-1.0%)
$3.75B(+4.0%)
Dec 1990
$3.60B(+15.1%)
$996.90M(+14.6%)
$3.60B(+38.2%)
Sep 1990
-
$869.70M(-2.9%)
$2.61B(+50.0%)
Jun 1990
-
$895.90M(+6.4%)
$1.74B(+106.4%)
Mar 1990
-
$842.10M
$842.10M
Dec 1989
$3.13B(+9.7%)
-
-
Dec 1988
$2.85B(+12.8%)
-
-
Dec 1987
$2.53B(+18.3%)
-
-
Dec 1986
$2.14B(+17.4%)
-
-
Dec 1985
$1.82B(+9.2%)
-
-
Dec 1984
$1.67B
-
-

FAQ

  • What is Abbott Laboratories annual gross profit?
  • What is the all time high annual gross profit for Abbott Laboratories?
  • What is Abbott Laboratories annual gross profit year-on-year change?
  • What is Abbott Laboratories quarterly gross profit?
  • What is the all time high quarterly gross profit for Abbott Laboratories?
  • What is Abbott Laboratories quarterly gross profit year-on-year change?
  • What is Abbott Laboratories TTM gross profit?
  • What is the all time high TTM gross profit for Abbott Laboratories?
  • What is Abbott Laboratories TTM gross profit year-on-year change?

What is Abbott Laboratories annual gross profit?

The current annual gross profit of ABT is $23.24B

What is the all time high annual gross profit for Abbott Laboratories?

Abbott Laboratories all-time high annual gross profit is $24.54B

What is Abbott Laboratories annual gross profit year-on-year change?

Over the past year, ABT annual gross profit has changed by +$1.11B (+5.01%)

What is Abbott Laboratories quarterly gross profit?

The current quarterly gross profit of ABT is $6.03B

What is the all time high quarterly gross profit for Abbott Laboratories?

Abbott Laboratories all-time high quarterly gross profit is $6.91B

What is Abbott Laboratories quarterly gross profit year-on-year change?

Over the past year, ABT quarterly gross profit has changed by +$347.00M (+6.10%)

What is Abbott Laboratories TTM gross profit?

The current TTM gross profit of ABT is $23.24B

What is the all time high TTM gross profit for Abbott Laboratories?

Abbott Laboratories all-time high TTM gross profit is $26.44B

What is Abbott Laboratories TTM gross profit year-on-year change?

Over the past year, ABT TTM gross profit has changed by +$1.11B (+5.01%)
On this page